Related Experiment Video
Updated: Jul 24, 2025

08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
14.0K
Functional MRI markers for treatment-resistant depression: Insights and challenges
Vasileia Kotoula1, Jennifer W Evans1, Claire Punturieri1
1Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Bethesda, MD, United States.
Progress in Brain Research
|July 6, 2023
Summary
Neuroimaging reveals altered brain connectivity and metabolites in treatment-resistant depression (TRD). Interventions like TMS show promise in reversing these changes, but more research is needed for definitive conclusions.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Treatment-resistant depression (TRD) poses a significant clinical challenge.
- Understanding the neurobiological underpinnings of TRD is crucial for developing effective treatments.
Purpose of the Study:
- To provide an overview of neuroimaging findings in TRD.
- To identify potential therapeutic targets based on brain alterations.
Main Methods:
- Review of studies utilizing structural magnetic resonance imaging (MRI), functional MRI (fMRI), and magnetic resonance spectroscopy (MRS).
Main Results:
- Consistent findings suggest decreased frontal brain connectivity and altered metabolite concentrations in TRD.
- Some interventions, such as transcranial magnetic stimulation (TMS), may reverse these neuroimaging changes.
Conclusions:
- Neuroimaging highlights potential pathophysiological mechanisms in TRD.
- Larger, standardized studies and data sharing are essential to advance TRD research and identify novel treatment targets.
Related Concept Videos
Brain Imaging
260
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
260
Antidepressant Drugs: MAOIs and Other Agents
277
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
277

